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ABSTRACT
Background: The ability to predict the development of allergic diseases in infants is important. Predictive
biomarkers are wanted to improve the risk evaluation in addition to known heredity of allergy. Biomarkers taken
during infancy need to be evaluated through longitudinal studies into adulthood. The objective of this study was
to analyse the occurrence of metachromatic cells in the nasal mucosa during infancy (MCinfancy) and evaluate
the cells as predictive biomarkers of allergy development.
Methods: Previously, MCinfancy occurrences were analysed in 64 infants with and without allergy heredity, and
related to allergy development at 18 months and 6 years of age. In this third follow-up at 18 years of age, cur-
rent allergy symptoms were analysed. MCinfancy findings were related to the cumulative number of allergic sub-
jects. The predictive values of MCinfancy and known heredity were compared.
Results: The cumulative number of subjects with allergy was 46, probable allergy 5, and no allergy 13. De-
tected MCinfancy predicted allergy with high accuracy (3133), but negative MCinfancy findings did not exclude the
risk (1531). In the group of allergic subjects positive MCinfancy were found in 3146 (67%), positive heredity in
3746 (80%) and oneboth factors positive in 4346 (93%). Detection of MCinfancy could precede the debut of
allergy symptoms by many years.
Conclusions: Detected MCinfancy predicted allergy development, but absence of MCinfancy did not exclude the
risk, and therefore this biomarker was not found to be adequate. There is a further need to find biomarkers with
high ability to both predict and exclude the risk.
KEY WORDS
allergy, cohort study, metachromatic cells, nasal epithelium, prediction
INTRODUCTION
Atopic disease is one of the most common chronic
disorders worldwide both among children and
adults.1,2 As the impact from these disorders on af-
fected individuals, their families and on the commu-
nity as a whole is considerable, measurements aim-
ing at prevention or reduction of allergy morbidity
are continuously regarded to be of great impor-
tance.3-5 In order to optimize all efforts, individuals at
risk who may best benefit from good clinical manage-
ment have to be identified early in life.6 Although a
family history of asthma and atopy is well known to
be one of the most important predictive factors,7-9
there is a need to improve risk evaluation. Thus,
much research has been done to identify additional
risk factors and predictive biomarkers. Sensitization
before the age of two years is found to be associated
with asthma at school age in children with parental
asthma or atopy.10 Environmental factors, such as ex-
posure to tobacco smoke and furry pets, are also re-
garded as risk factors for respiratory symptoms.11
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Understanding the immunological mechanisms un-
derlying inflammation has identified a number of
biomarkers, but few of them have proven useful as
predictors.12 The recent advances in technology in
studies of functional genomics13 may be a method for
ensuring the best reliable predictive biomarkers, but
as findings analysed during infancy need to be evalu-
ated through longitudinal studies into adulthood, the
results using this relatively new method will be de-
layed for another one or two decades.
Our ambition to find biomarkers during infancy for
allergy development by means of a simple test proce-
dure started with a prospective study, including 67 in-
fants between 1985 and 1988. Most of the invited in-
fants had a history of allergy in immediate family
members, ensuring development of atopy in early
life. A smaller group with no family history of allergy
was included to ensure healthy controls.
The main focus of the study was on the occurrence
of metachromatic cells (MC, mast cells, basophils) in
the nasal mucosa, as new information on human MC
heterogeneity had recently become available at the
time of the study start.14 Specimens for cell analysis
were taken repeatedly from the nasal mucosa during
infancy and could be evaluated in 64 babies. At the
first follow-up at 18 months of age, findings of demon-
strable MC during infancy (MCinfancy) were signifi-
cantly associated with allergy, both for respiratory
tract symptoms and for atopic dermatitis.15 Nasal eo-
siophils were commonly found in allergic and also in
healthy children and therefore considered to be of
less diagnostic and predictive value.16 The association
between MCinfancy and allergy development still per-
sisted at the second follow-up at 6 years of age.17
The aim of this third follow-up was to analyse, after
getting detailed information and examinations of cur-
rent allergy symptoms, if the association between
MCinfancy and allergy development still persisted at
the age of 18 years. Based on this result the value of
MCinfancy findings as predictive biomarker for allergy
development could be evaluated and compared to the
predictive value of allergy heredity.
METHODS
SUBJECTS
The original study group comprised 67 children.
Specimens for analysis of MC occurrence in the nasal
mucosa had been taken at 3, 6, 9 and 18 months of
age (MCinfancy) in 64 infants, while results from three
babies could not be evaluated due to insufficient com-
pliance with the repeated examinations during in-
fancy.15 MCinfancy were detected in 33 and not de-
tected in 31 infants.
The family history of allergy was previously estab-
lished in detail.15 Briefly, the definition of a positive
allergy heredity was based on a history in immediate
family members of allergy symptoms in the upper
lower airways verified by a positive skin prick test to
a relevant air-born allergen andor a history of atopic
eczema; possible allergy heredity was defined as a
history of mild airway allergy not verified by the skin
prick test, or no allergy history but a positive skin
prick test, or a history of atypical eczema; negative
heredity was defined as a history of healthy immedi-
ate family members verified by negative skin prick
tests. Allergy heredity in the 64 infants with assessed
findings of MCinfancy was found to be positive in 44,
possible in 11 and negative in only 9 subjects.
In this 18-year follow-up, information on allergy de-
velopment was obtained from all of the individuals in
the original cohort by questionnaires, personal inter-
views and telephone calls, and the invitation to par-
ticipate in various examinations was accepted by 49 of
them. Test results from subjects, who reported cur-
rent treatment with pharmacological agents with pos-
sible effects on the results, were excluded in the sta-
tistical evaluations. The numbers of included values
in the separate tests are shown in the ‘Results’ sec-
tion.
This follow-up was performed during wintertime
out of the pollen season. The participants had to be
free from airway infections for at least 10 days prior
to the examinations.
CLINICAL EXAMINATIONS
All of the participants were examined by anterior rhi-
noscopy, inspection of the throat, epipharynx, hypo-
pharynx and larynx, and by otomicroscopy and tym-
panometry.
QUESTIONNAIRE
The questions about upper and lower airways and the
skin were based on questionnaire modules for teen-
agers in the study protocol for ISAAC studies.18 Addi-
tional questions about time relations between expo-
sure to offending allergens and airway symptoms and
the current use of pharmaceutical agents were added.
SKIN PRICK TEST AND PHADIATOPⓇ ANALY-
SIS
A skin prick test (SPT) was performed using ALK ex-
tracts (ALK, Denmark) including pollen allergens
(birch, timothy, mugwort) and perennial allergens
(horse, cat, dog, D pteronyssinus, D. farinae, Alter-
naria, Cladosporium). The SPT was defined as posi-
tive if the mean wheal diameter (half of the sum of
the largest diameter and its perpendicular) was at
least 3 mm.15 Histamine hydrochloride 10 mgml
served as a positive control and normal serum albu-
min was used as a negative control. ImmunoCAPⓇ
(Phadia AB, Uppsala, Sweden) with the correspond-
ing allergens as in SPT was used in one male with al-
lergy including severe eczema. Sensitization to inha-
lant allergens was also examined in all of the subjects
by PhadiatopⓇ analysis (Phadia AB, Uppsala, Swe-
den). Positive results in the serological analyses were
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values above the detection limit of 0.35 kUL, accord-
ing to the manufacturer.
DEFINITIONS OF ALLERGY DIAGNOSES
The definitions of allergic rhino-conjuctivitis and al-
lergic bronchial symptoms were based on a history of
relevant symptoms (itching in eyes or nose, tearing,
eye redness, runny nose, sneezing, nasal obstruction,
shortness of breath, chest wheezingwhistling, in-
creased mucus production, coughing) during the last
two years at least twice in relation to exposure to an
airborne allergen. The symptoms had to be sup-
ported by at least one positive SPT reaction and a
positive PhadiatopⓇ test. The definition of asthma
was according to the changes in the spirometric re-
sults in the exercise provocation test (see below).
Atopic eczema was evaluated according to the SCO-
RAD index.19 Symptoms not fulfilling all of the crite-
ria were defined as ‘probable allergy’. A symptom-
free period during the last two years in relation to
previously offending allergen exposures was re-
garded as recovery from disease.
EXERCISE PROVOCATION TEST AND ASTHMA
DEFINITION
A standardized method was used to evaluate the func-
tion in the lower airways. The individuals had to run
on a treadmill for 6 minutes to achieve a pulse rate of
160 beats per minute. Spirometry (Microlab) was
performed before exercise, immediately after exer-
cise and repeated after another 15 minutes; a reversal
dose of a β-agonist was then given followed by a
fourth measurement 15 minutes later.
Asthma definition was based on the values of the
forced expiratory volume in 1 second (FEV1): an in-
itial FEV1 value80% of the expected value, a reduc-
tion of FEV115% after the physical exercise in com-
bination with an increase of FEV1 15% after the
bronchodilatation. Individuals reporting relevant
symptoms from the chest related to allergen expo-
sures but not fulfilling the asthma criteria were re-
garded to suffer from allergic bronchitis.
CYTOSPIN PREPARATIONS OF NASAL MU-
COSAL CELLS
Nasal mucosal cells were harvested by a gentle nasal
brushing using a 5.5 mm diameter nylon brush (Doft
AB, Östhammar, Sweden). The brush was immedi-
ately placed in a tube containing physiological saline
and twirled for several seconds. After cytocentrifuga-
tion onto glass slides, the materials were air-dried
and fixated in 95% ethanol for later staining with tolu-
idine blue for analysis of MC, according to the
method used in our previous follow-ups.15,17 Analysis
of the numbers of MC was performed blindly by light
microscopy (magnification ×250) with slides coded.
Occurrence of one or more MC was regarded as a
positive result, and absence of demonstrable MC as a
negative result, provided the density of epithelial cells
was >25 cells per visual field.
STATISTICAL ANALYSIS
Fisher’s exact test was used when comparing two
qualitative data results between two groups. A prob-
ability level of less than 5% was considered to be sig-
nificant.
ETHICS
The study was approved by the Ethical Committee at
the University Hospital in Linköping, Sweden
(03694). A written consent was obtained from each of
the participants after full information of the study.
RESULTS
CLINICAL MANIFESTATIONS OF ALLERGY AND
TEST RESULTS AT THE AGE OF 18 YEARS
Diagnosis of Allergy by History of Symptoms
and Findings at the Clinical Examinations
The history of allergy symptoms from the 67 partici-
pants revealed current allergy symptoms in 39 indi-
viduals, probable allergy in four and no allergy in 24
individuals.
The development of allergy from all follow-ups is
shown in Figure 1. The details from the first two
follow-ups are presented previously.15,17 Since the
previous 6-year follow-up, ten individuals reported de-
but of symptoms, two of the six individuals with previ-
ous recovery had regained allergy symptoms, and
only one subject had recovered at this follow-up.
The most common problems at the age of 18 years
were symptoms in the upper airways, which was a
shift among allergy symptoms, as skin and bronchial
symptoms were previously dominating during in-
fancy and preschool age (Table 1). Thus, nasal symp-
toms were reported by all individuals with airway
symptoms and in 11 of the 17 subjects with skin
symptoms.
The clinical findings were normal in most individu-
als, probably due to the examinations being per-
formed during winter time with a symptom free inter-
val in the pollen sensitive subjects and weak influ-
ences from allergen exposures in subjects with per-
ennial allergy.
There was a trend toward a higher number of indi-
viduals reporting allergy symptoms among those at-
tending the clinic for tests (3149) compared to those
who refrained from the visit (818).
Allergy Tests
Signs of sensitization, according to positive findings
in the allergy tests, were evaluated in all of the 49 in-
dividuals accepting the invitation for examination.
The SPT results were in agreement with the Phadia-
topⓇ analyses in all except one subject, who had re-
covered from previous allergy and was SPT negative
but Phadiatop positive. The allergy tests were posi-
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Table 1 Number of individuals and the percentage (in pa-
rentheses) of diferent alergy symptoms at the folow-ups
18 years
(n = 67)
6 years‡
(n = 67)
18 months†
(n = 64)
History of
alergy symptoms
392930Alergy symptoms
17/2216/1318/12- single/multiple
- symptoms in the:
17 (44%)19 (66%)21 (70%)skin
15 (38%)§11 (38%)16 (53%)lower airways
33 (85%)16 (55%) 2 ( 7%)upper airways
 4 5 9Probable alergy
243325No alergy
†data from reference 15; ‡data from reference 17; §asthma 
verified in 2/15 individuals reporting bronchial alergy 
symptoms.
Fig. 1 Number of subjects reporting alergy (A), probable alergy (?) and no alergy symptoms (NA) at 
the folow-ups at 18 months, 6 years and 18 years of age.
67
not evaluated
3
at 18 years
at 6 years
Classification
at 18 months
Number of children
included at birth
NA
25
?
9
A
30
A
22
?
2
?
1
NA
6
A
5
NA
19
NA
13
NA
1
?
1
?
2
?
1
A
21
NA
2
NA
2
?
1
?
1
A
1
A
1
A
1
A
2
A
2
A
2
A
2
A
2
NA
4
NA
4
A
5
NA
6
A
2
tive to at least one allergen in 26 out of 27 individuals
with airway allergy; one man with a convincing his-
tory of birch pollen allergy was negative in both of
the tests. According to the profile of sensitization the
subjects with airway allergy were grouped into a sub-
group sensitized only to pollens (n = 8) and a sub-
group sensitized to perennial allergens regardless of
concomitant positive pollen test (n = 18). The tests
were negative in all of the four individuals with symp-
toms limited to the skin, in three of the four individu-
als with probable airway allergy and in all of the 14
non-allergic individuals.
Thus, there was a high agreement between signs
of sensitization in individuals reporting airway symp-
toms (96%), and no signs of sensitization in healthy
individuals (100%) and in subjects with symptoms lim-
ited to the skin (100%).
Exercise Test
The exercise test was performed in 47 individuals, as
two subjects with upper and lower airway symptoms
refrained from performing the test due to personal
reasons. The test was normal in all subjects with no
symptoms in the lower airways. Out of 11 individuals
reporting allergic symptoms in the lower airways, the
criteria of asthma diagnosis were fulfilled in only two
subjects, both sensitized to perennial and pollen aller-
gens, and nine were regarded to suffer from allergic
bronchitis.
MC Findings
Occurrence of nasal MC (MC18 years) was evaluated in
45 individuals, as two subjects were using pharma-
cological agents, which might have had effects on the
cell findings (non-allergic systemic diseases treated
with methotrexate and oral steroids, respectively)
and another two subjects refrained from the nasal
brushing due to personal reasons.
The number of individuals with demonstrable
MC18 years were significantly higher (p = 0.01) in the
group with allergy symptoms (1630) compared to
the group of individuals with no allergy (112). How-
ever, no statistical difference was found in the num-
ber of subjects with demonstrable MC18 years when
MC During Infancy and Allergy Prediction
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Table 2 Number of subjects with findings of metachro-
matic cels (MC18 years) related to curent alergy symptoms 
and alergen sensitization at the 18-year folow-up
Totalsnot present
MC18 years
present
History of alergy
symptoms in:
 4 3 1Skin only
Airways
alergen sensitization
 8 4 4- polens only
17 710- perennials
 1 0 1not sensitized
 3 1 2Probable airways
1211 1No alergy
452619Totals
A smal subset of subjects with airway alergy had also mild 
eczema. A subset of subjects sensitized to perennials was also 
sensitized to polens.
comparing the allergy subgroups sensitized to pol-
lens only and to perennial allergens (48 and 1017,
respectively, Table 2).
DEVELOPMENT OF ALLERGY SYMPTOMS
FROM INFANCY TO THE AGE OF 18 YEARS IN
RELATION TO THE METACHROMATIC CELL
FINDINGS DURING INFANCY AND TO THE FAM-
ILY HISTORY OF ALLERGY
Reports of allergy symptoms could be obtained in this
third follow-up from all of the 64 individuals with as-
sessed findings of MCinfancy and known allergy hered-
ity. During the period of 18 years, altogether 46 of the
64 individuals were suffering (n = 38) or had been
suffering previously (n = 8) from allergy symptoms,
five had reported probable symptoms during the pe-
riod, while 13 subjects never had experienced any al-
lergy symptoms (Fig. 1).
Predictive Value of MCinfancy
In the group of individuals with demonstrable
MCinfancy, allergy developed in 3133 (94%), probable
allergy in 233 and none remained healthy. The inter-
vals until debut of allergy symptoms with clinical
manifestations in airways andor skin in relation to
findings of MCinfancy are shown in Table 3. In most of
the MCinfancy positive individuals symptoms devel-
oped during infancy, but in one third of the subjects
the debut of allergic symptoms was delayed until pre-
school age or adolescence. Fourteen of 19 subjects
with positive MC18-years findings were MCinfancy posi-
tive and five subjects were MCinfancy negative.
MCinfancy were demonstrated in the respiratory mu-
cosa in four of the five subjects developing atopic ec-
zema without airway symptoms.
In the group of individuals with no detectable
MCinfancy, 1331 (42%) remained healthy, 331 (10%)
suffered from probable allergy and 1531 (48%) devel-
oped allergy symptoms.
Predictive Value of Allergy Heredity
In the group of subjects with a positive family history
of allergy, 3744 (84%) developed allergy, 344 (7%)
reported probable allergy and 444 (9%) remained
free from allergy symptoms. Among the subjects with
no heredity, 39 developed allergy problems and 69
remained healthy.
Predictive Value of Combined Information from
MCinfancy Findings and Allergy Heredity
Positive findings of MCinfancy andor positive allergy
heredity were found in 51 subjects, and 4351 (84%)
developed allergy, 451 (8%) probable allergy and 4
51 (8%) remained healthy. Among individuals with no
demonstrable MCinfancy and negative heredity, 28
developed allergy problems and 68 remained
healthy.
Thus, among the subjects developing allergy 3146
(67%) had positive MCinfancy findings, 3746 (80%) had
a positive heredity of allergy, and in 4346 (93%) of
the subjects either or both of predictive factors were
positive.
DISCUSSION
This study demonstrated that detection of MC in na-
sal epithelium during infancy is associated with devel-
opment of allergic symptoms up to the age of 18
years, as all of the individuals with demonstrable
MCinfancy developed allergy or, in a few individuals,
suspected allergy symptoms and none of them re-
mained completely free from allergy problems. De-
tection of the MCinfancy often preceded the debut of al-
lergy symptoms during infancy15 and childhood17 and
this follow-up showed an interval of many years with
debut of allergy symptoms not before adolescence in
some subjects. It is also interesting to note that
MCinfancy in nasal mucosa were found, not only in in-
dividuals developing airway allergy, but also in indi-
viduals developing atopic eczema without airway
symptoms. These findings are in agreement with the
concept of atopy as a systemic disease.
Our findings of demonstrable MCinfancy have lead
us to some speculations, although we have no ambi-
tion to give an adequate explanation for the develop-
ment of allergy diseases. One of our speculations is,
that subjects with a propensity for allergy develop-
ment might have an innate constitution with a higher
number of MC, as reflected by the MCinfancy findings,
regardless of future symptoms in lower airways, skin
as well as in the upper respiratory tract, described as
the atopic march. The presence of MC early in life
might contribute to sensitization, as mast cells have
been proposed to be promotors of local IgE synthesis
via B cell activation.20,21 We also have speculated that
an MCinfancy, provided that the infiltration in the nasal
mucosa has a corresponding MCinfancy infiltration in
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Table 3 Number of subjects with/without nasal metachromatic cels during infancy (MCinfancy) in relation to debut of alergy 
symptoms during the entire period up to 18 years of age
Never
alergy
Probable
alergy
Symptoms in First report of alergy
symptoms at the age of:
18 months/6 years/18 years
MCinfancy skin
only
airways
± skin 
 024276520Present (n = 33)
1331143210Not present (n = 31)
1355419730Totals
Subgroups with symptoms in airways (with/without skin symptoms) and the skin only are also shown.
the bronchial wall, might contribute to the develop-
ment of asthma, as mast cells are found in increased
in numbers within the airway smooth muscle bundles
of asthmatic patients22 and this infiltration has been
related to airway dysfunction and asthma severity.23
In contrast to the possibility of future allergy pre-
diction based on detectable MCinfancy, absence of
MCinfancy findings did not exclude the risk of allergy
development. In all of the three follow-ups absence of
MC were found in a proportion of individuals ex-
pected to have demonstrable MC due current allergy
symptoms.
One explanation for not finding expected occur-
rence of MC in this 18-year follow-up might be the
time of the year of the examinations, which were per-
formed out of the pollen season to ensure the same
environmental conditions to all of the participants.
Provided the same redistribution of mast cells from
the lamina propria to the epithelium, as described af-
ter exposure in pollen allergic patients,24,25 also takes
place due to exposure to perennial allergens, reduced
numbers of subjects with detectable MC18 years could
be expected in the subgroup sensitized to only pol-
lens with no allergen exposure for more than three
months compared to the subgroup sensitized to per-
ennial allergens with persistent allergen exposure.
However, no statistical difference in the number of
subjects withwithout detectable MC18 years was
found between the two groups. The exposures to per-
ennial allergens might have been too weak for a re-
distribution of MC, and the limited number of sub-
jects in the two subgroups might also explain the ab-
sence of a group difference.
The proportion of allergic subjects with demonstra-
ble MC was decreased at the 18-year follow-up (19
45) compared to the 18-month follow-up (3364). This
is probably explained by allergy to foods, which was
common in during infancy, but resolved in most of
the food allergic subjects in young adulthood. Nasal
mast cells have been demonstrated in children with
ongoing allergy to food only.26
A possible explanation for not detecting MC may
also be false negative findings, overlooking single
MC in dense areas of epithelial cells. The metachro-
matic staining procedure and analysis by light mi-
croscopy was the only method available at the start of
our cohort study, and has been used in all of the
three follow-ups. Improved information of MC infiltra-
tion would have been obtained by methods including
specific antibodies to mast cell subtypes and baso-
phils, as used in immunocytochemistry or laser scan-
ning cytometry.27,28 However, in a study on cellular
infiltrates in allergic children based on findings of
specific antibodies to mast cells and other cells in mu-
cosal biopsies, the results were in agreement with
our study, as unexpected absence of mast cells in the
epithelium was found in a proportion of allergic chil-
dren sensitized to aeroallergens.29 In the future,
microarray-based studies of genes and transcripts in
cells will probably result in superior information on
predictive biomarkers, as this technique has shown
genes exclusively expressed in mast cells and other
cells in subjects with current allergy.13,30
The family history of allergy is since long regarded
as ‘the golden standard’ as a predictor in risk evalu-
ation of allergy development. In our cohort study, the
group with no allergy heredity was inadmissibly re-
duced at the detailed check-up of the family mem-
bers15 resulting in a small control group of individuals
with a negative heredity but an unwanted group of
subjects with possible heredity. However, the study
showed, that the detailed family history of allergy was
a good predictor of allergy in individuals with a posi-
tive heredity.
The over-all predictive value of heredity was higher
compared to the over-all predictive value of MCinfancy
findings, due to the fact that negative cell findings did
not identify a large proportion of the risk subjects.
The best risk evaluation was achieved by combined
information on positive heredity and positive
MCinfancy findings. Unfortunately, the risk could not
be excluded with negative findings of these two fac-
tors in combination.
The development of allergy symptoms in our co-
hort followed the well-known changes in atopic mani-
festation from infancy to adulthood, described as ‘the
atopic march’.31 Atopic dermatitis, being predominant
during infancy15 and pre-school age17 had gradually
resolved in many of the sufferers, and most of the 46
subjects with previous or current allergy had devel-
oped airway symptoms. Only five of them had suf-
fered from atopic eczema with no airway symptoms.
At the age of 18 years asthma manifestations were
less pronounced in severity as compared to the previ-
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ous follow-ups and allergic rhinitis was the most com-
mon symptom. Examinations outside the peak of
their symptom period may explain why subjects re-
porting pollen related relevant symptoms in the lower
airways did not reach the criteria for asthma diagno-
sis, and therefore were classified as having allergic
bronchitis.
The ascertainment of correct diagnoses from case
histories was provided by the PhadiatopⓇ and SPT in
those individuals attending the clinic. The informa-
tion from the case history was in high agreement
with the results from both of the allergy tests. Thus,
it was assumed that the subjects evaluated at a dis-
tance without the availability of allergy tests were cor-
rectly classified into the group with current allergy
and the healthy group, respectively.
The strength of this study is the long follow-up pe-
riod, so that allergy development up to young adult-
hood could be followed in all of the included infants.
Few cohort studies, with the aim of evaluating early
biomarkers of allergic diseases in children, have fol-
lowed individuals into adult life. Piippo-Savolainen et
al. followed 83 children prospectively in order to
evaluate if early sensitization can predict asthma.32
Sixty-five percent of the children remained in their
study at the age of 18-20 years, and they found that
early sensitization to seasonal pollen predicts subse-
quent asthma among adolescents.
We conclude, that nasal MCinfancy, if detected, pre-
dicted allergy development with high accuracy. To
our knowledge, the long interval found in many of the
individuals between the detection of nasal MC during
infancy and debut of allergy not before adolescence is
not previously described. This time period might be
used for important preventive measurements. How-
ever, due to negative MCinfancy findings in a high pro-
portion of subjects developing allergy, the over-all
predictive value was lower than the over-all predictive
value of a detailed family history of allergy. In spite of
an increased risk evaluation by the combined infor-
mation of heredity and cell findings, we do not regard
the MCinfancy as an adequate predictive biomarker of
allergy development. Further studies, using im-
proved methods of cell analyses or studies at the
gene level, are needed to find biomarkers with high
accuracy to predict and also to exclude the risk of al-
lergy development.
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